Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Maxigen Biotech Inc. (1783.TW), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
11.53
P/B ratioShare price divided by book value per share.
2.23
P/S ratioMarket value divided by annual revenue.
3.99
PEG ratioP/E divided by the earnings growth rate.
0.34
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
8.40
EV / RevenueEnterprise value against annual revenue.
2.92
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
8.67%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
69.91%
Operating marginRevenue left after operating costs.
25.69%
Net marginRevenue left after every cost, including tax and interest.
34.77%
Return on equityProfit as a percentage of shareholders’ equity.
20.00%
Return on assetsProfit as a percentage of total assets.
8.55%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.33
Quick ratioThe same, excluding inventory.
2.13
Debt to equityTotal borrowings against shareholders’ equity.
0.07
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$3.23
Book value per shareShareholders’ equity divided by shares outstanding.
$16.71
Shares outstandingShares currently issued.
89,698,000
Market capitalisationShare price times shares outstanding.
$3.42B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
127
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
5.25%
Payout ratioShare of profit paid out as dividends.
60.53%
Maxigen Biotech Inc. (1783.TW) statistics — frequently asked questions
What is Maxigen Biotech Inc.'s P/E ratio?
Maxigen Biotech Inc. (1783.TW) trades on a price-to-earnings ratio of 11.53.
What is Maxigen Biotech Inc.'s return on equity?
Maxigen Biotech Inc. (1783.TW) reports a return on equity of 20.00%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Maxigen Biotech Inc. carry?
Maxigen Biotech Inc. (1783.TW) has a debt-to-equity ratio of 0.07, which compares total borrowings with shareholders' equity.
What is Maxigen Biotech Inc.'s profit margin?
Maxigen Biotech Inc. (1783.TW) keeps 34.77% of revenue as net profit after every cost, including tax and interest.